These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20185819)

  • 1. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.
    Bista P; Zeng W; Ryan S; Bailly V; Browning JL; Lukashev ME
    J Biol Chem; 2010 Apr; 285(17):12971-8. PubMed ID: 20185819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100.
    Fusco AJ; Mazumder A; Wang VY; Tao Z; Ware C; Ghosh G
    Sci Signal; 2016 Sep; 9(447):ra96. PubMed ID: 27678221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor.
    Ganeff C; Remouchamps C; Boutaffala L; Benezech C; Galopin G; Vandepaer S; Bouillenne F; Ormenese S; Chariot A; Schneider P; Caamaño J; Piette J; Dejardin E
    Mol Cell Biol; 2011 Nov; 31(21):4319-34. PubMed ID: 21896778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs.
    Mukherjee T; Chatterjee B; Dhar A; Bais SS; Chawla M; Roy P; George A; Bal V; Rath S; Basak S
    EMBO J; 2017 Dec; 36(23):3501-3516. PubMed ID: 29061763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
    Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
    Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
    Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc-finger protein 91 plays a key role in LIGHT-induced activation of non-canonical NF-κB pathway.
    Jin HR; Jin X; Lee JJ
    Biochem Biophys Res Commun; 2010 Oct; 400(4):581-6. PubMed ID: 20804734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKK4 activates non-canonical NFκB signaling by promoting NFκB2-p100 processing.
    Kim JS; Kim EJ; Kim HS; Kurie JM; Ahn YH
    Biochem Biophys Res Commun; 2017 Sep; 491(2):337-342. PubMed ID: 28733031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
    He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
    J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
    Song YJ; Kang MS
    Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XEDAR activates the non-canonical NF-κB pathway.
    Verhelst K; Gardam S; Borghi A; Kreike M; Carpentier I; Beyaert R
    Biochem Biophys Res Commun; 2015 Sep; 465(2):275-80. PubMed ID: 26260321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.
    Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF
    J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
    Farhana L; Dawson MI; Murshed F; Fontana JA
    Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
    Müller JR; Siebenlist U
    J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
    Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
    Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFκB-inducing kinase inhibits NFκB activity specifically in neurons of the CNS.
    Mao X; Phanavanh B; Hamdan H; Moerman-Herzog AM; Barger SW
    J Neurochem; 2016 Apr; 137(2):154-63. PubMed ID: 26778773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
    Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
    Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic subunits of the phosphatase calcineurin interact with NF-κB-inducing kinase (NIK) and attenuate NIK-dependent gene expression.
    Shinzawa M; Konno H; Qin J; Akiyama N; Miyauchi M; Ohashi H; Miyamoto-Sato E; Yanagawa H; Akiyama T; Inoue J
    Sci Rep; 2015 Jun; 5():10758. PubMed ID: 26029823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
    Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
    Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.